DK1539783T3 - Inhibitorer af nucleosidphosphorylaser og nucleosidaser - Google Patents
Inhibitorer af nucleosidphosphorylaser og nucleosidaserInfo
- Publication number
- DK1539783T3 DK1539783T3 DK03792904.9T DK03792904T DK1539783T3 DK 1539783 T3 DK1539783 T3 DK 1539783T3 DK 03792904 T DK03792904 T DK 03792904T DK 1539783 T3 DK1539783 T3 DK 1539783T3
- Authority
- DK
- Denmark
- Prior art keywords
- inhibitors
- compounds
- phosphorylases
- nucleosidases
- methylthioadenosine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrane Compounds (AREA)
- Seal Device For Vehicle (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ52091902 | 2002-08-21 | ||
PCT/NZ2003/000186 WO2004018496A1 (en) | 2002-08-21 | 2003-08-21 | Inhibitors of nucleoside phosphorylases and nucleosidases |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1539783T3 true DK1539783T3 (da) | 2011-06-20 |
Family
ID=31944950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03792904.9T DK1539783T3 (da) | 2002-08-21 | 2003-08-21 | Inhibitorer af nucleosidphosphorylaser og nucleosidaser |
Country Status (18)
Country | Link |
---|---|
US (2) | US7553839B2 (da) |
EP (1) | EP1539783B1 (da) |
JP (1) | JP4682314B2 (da) |
KR (1) | KR101081226B1 (da) |
CN (1) | CN100379750C (da) |
AT (1) | ATE505474T1 (da) |
AU (1) | AU2003258911B2 (da) |
BR (1) | BRPI0313664B8 (da) |
CA (1) | CA2496698C (da) |
CY (1) | CY1111700T1 (da) |
DE (1) | DE60336734D1 (da) |
DK (1) | DK1539783T3 (da) |
ES (1) | ES2363766T3 (da) |
HK (1) | HK1085219A1 (da) |
PT (1) | PT1539783E (da) |
RU (1) | RU2330042C2 (da) |
SI (1) | SI1539783T1 (da) |
WO (1) | WO2004018496A1 (da) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5985848A (en) | 1997-10-14 | 1999-11-16 | Albert Einstein College Of Medicine Of Yeshiva University | Inhibitors of nucleoside metabolism |
US6693193B1 (en) * | 1999-04-08 | 2004-02-17 | Industrial Research Limited | Process for preparing 2-pyrrolidinyl-1H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside metabolism |
EP1539783B1 (en) | 2002-08-21 | 2011-04-13 | Albert Einstein College Of Medicine Of Yeshiva University | Inhibitors of nucleoside phosphorylases and nucleosidases |
NZ523970A (en) * | 2003-02-04 | 2005-02-25 | Ind Res Ltd | Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases |
TW200519116A (en) * | 2003-08-26 | 2005-06-16 | Teijin Pharma Ltd | Pyrrolopyrimidine derivatives |
US7557113B2 (en) | 2003-08-26 | 2009-07-07 | Teijin Pharma Limited | Substituted pyrrolo[3,2-d]pyrimidine derivatives |
NZ533360A (en) * | 2004-06-04 | 2007-02-23 | Ind Res Ltd | Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
US20090012104A1 (en) * | 2004-07-27 | 2009-01-08 | Babu Yarlagadda S | Inhibitors of 5'-Methylthioadenosine Phosphorylase and 5'-Methylthioadenosine/S-Adenosylhomocysteine Nucleosidase |
NZ540160A (en) * | 2005-05-20 | 2008-03-28 | Einstein Coll Med | Inhibitors of nucleoside phosphorylases |
EP1924684A4 (en) * | 2005-07-27 | 2009-02-11 | Einstein Coll Med | STRUCTURE OF TRANSITION STATUS OF 5'-METHYLTHIOADENOSINE / S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASES |
NZ544187A (en) * | 2005-12-15 | 2008-07-31 | Ind Res Ltd | Deazapurine analogs of 1'-aza-l-nucleosides |
US20090053221A1 (en) * | 2006-01-17 | 2009-02-26 | Cheung Nai-Kong V | Immune response enhancing glucan |
US8394950B2 (en) * | 2006-02-22 | 2013-03-12 | Industrial Research Limited | Analogues of coformycin and their use for treating protozoan parasite infections |
AU2007218334A1 (en) * | 2006-02-24 | 2007-08-30 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of treating diseases using inhibitors of nucleoside phosphorylases and nucleosidases |
AU2006200809B2 (en) * | 2006-02-24 | 2013-11-07 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of treating cancer |
WO2007097647A1 (en) * | 2006-02-24 | 2007-08-30 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of treating cancer |
CN101094080B (zh) * | 2006-06-22 | 2012-06-20 | 华为技术有限公司 | 一种即按即通系统中的计费方法 |
AU2007293773B2 (en) * | 2006-09-07 | 2013-01-31 | Albert Einstein College Of Medicine, Inc. | Acyclic amine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase |
EP2395005A1 (en) | 2006-09-07 | 2011-12-14 | Industrial Research Limited | Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
US8283345B2 (en) | 2006-12-22 | 2012-10-09 | Industrial Research Limited | Azetidine analogues of nucleosidase and phosphorylase inhibitors |
WO2009082247A1 (en) * | 2007-12-21 | 2009-07-02 | Industrial Research Limited | Process for preparing immucillins having a methylene link |
UA103195C2 (uk) | 2008-08-11 | 2013-09-25 | Глаксосмитклайн Ллк | Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань |
EP2348854A4 (en) * | 2008-09-22 | 2012-03-14 | Einstein Coll Med | METHOD AND COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS BY INHIBITING THE "QUORUM SENSING |
SG174517A1 (en) * | 2009-03-24 | 2011-10-28 | Biocryst Pharm Inc | Useful pharmaceutical salts of 7-[(3r, 4r)-3-hydroxy-4-hydroxymethyl-pyrrolidin-1-ylmethyl]-3,5-dihydro-pyrrolo[3,2-d]pyrimidin-4-one |
WO2011008110A1 (en) | 2009-07-17 | 2011-01-20 | Albert Einstein College Of Yeshiva University | 3-hydroxypyrrolidine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase |
US9290501B2 (en) | 2010-11-29 | 2016-03-22 | Albert Einstein College Of Medicine, Inc. | Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase |
WO2012122532A2 (en) * | 2011-03-09 | 2012-09-13 | Biocryst Pharmaceuticals, Inc. | Compositions and methods for treatment of hyperuricemia |
LT2734186T (lt) | 2011-07-22 | 2018-12-10 | Glaxosmithkline Llc | Kompozicija |
JP6063571B2 (ja) * | 2012-08-07 | 2017-01-18 | アルバート アインシュタイン カレッジ オブ メディシン,インコーポレイティド | ヘリコバクター・ピロリ感染の治療 |
ES2653254T3 (es) | 2012-08-24 | 2018-02-06 | Glaxosmithkline Llc | Compuestos de pirazolopirimidina |
EP2920179A4 (en) | 2012-11-12 | 2016-03-30 | Victoria Link Ltd | SALT FORMS AND POLYMORPHIC FORMS OF (3R, 4S) -1 - ((4-AMINO-5H-PYRROLO [3,2-D] PYRIMIDIN-7-YL) METHYL) -4- (METHYLTHIOMETHYL) PYRROLIDIN-3-OL (MTDIA) |
CN104780922B (zh) | 2012-11-20 | 2016-09-07 | 葛兰素史克有限责任公司 | 干扰素诱导剂化合物 |
AU2013348216B2 (en) | 2012-11-20 | 2016-10-13 | Glaxosmithkline Llc | Novel compounds |
WO2014081644A1 (en) | 2012-11-20 | 2014-05-30 | Glaxosmithkline Llc | Novel compounds |
US9452217B2 (en) | 2013-06-22 | 2016-09-27 | Nitor Therapeutics | Methods for potentiating immune response for the treatment of infectious diseases and cancer |
JP6512613B2 (ja) | 2014-02-12 | 2019-05-15 | アルバート アインシュタイン カレッジ オブ メディシン,インコーポレイティド | Mtan阻害剤を使用するピロリ菌(h.pylori)感染の治療 |
EP2913333A1 (en) * | 2014-02-27 | 2015-09-02 | Laboratoire Biodim | 3H-thieno[3,4]pyrimidin-4-one and pyrrolopyrimidone as gram-positive antibacterial agents |
CN108794628A (zh) * | 2018-05-28 | 2018-11-13 | 广东工业大学 | 一种抗幽门螺杆菌的卵黄抗体制备方法及应用 |
GB202110403D0 (en) | 2021-07-20 | 2021-09-01 | Laevoroc Immunology | Ulodesine Salt |
GB202218782D0 (en) | 2022-12-13 | 2023-01-25 | Mehrling Thomas | Purine nucleoside phosphorylase inhibitor for metabolic syndrome |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2072123C (en) * | 1989-10-31 | 2001-06-12 | John A. Secrist, Iii | Inhibitors of purine nucleoside phosphorylase |
JPH07242668A (ja) * | 1994-03-08 | 1995-09-19 | Nippon Kayaku Co Ltd | 新規なアゼチジン誘導体 |
HUT77436A (hu) * | 1994-10-05 | 1998-04-28 | Darwin Discovery Limited | Purin- és guaninszármazékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk gyógyszerkészítmények előállítására |
KR100424934B1 (ko) | 1995-03-29 | 2004-07-27 | 다이호야쿠힌고교 가부시키가이샤 | 우라실유도체및이를함유하는항종양효과증강제및항종양제 |
WO1997031008A1 (en) | 1996-02-23 | 1997-08-28 | Industrial Research Limited | Enzyme detection/assay method and substrates |
US5985848A (en) | 1997-10-14 | 1999-11-16 | Albert Einstein College Of Medicine Of Yeshiva University | Inhibitors of nucleoside metabolism |
US6693193B1 (en) | 1999-04-08 | 2004-02-17 | Industrial Research Limited | Process for preparing 2-pyrrolidinyl-1H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside metabolism |
US6448799B1 (en) * | 1999-09-30 | 2002-09-10 | Hitachi Electronics Engineering Co., Ltd. | Timing adjustment method and apparatus for semiconductor IC tester |
JP4110347B2 (ja) | 1999-11-05 | 2008-07-02 | 大鵬薬品工業株式会社 | 抗hiv剤 |
AU2001284564A1 (en) * | 2000-08-29 | 2002-03-13 | Albert Einstein College Of Medicine Of Yeshiva University | Nucleoside metabolism inhibitors |
US6458799B1 (en) | 2000-08-31 | 2002-10-01 | Biocryst Pharmaceuticals, Inc. | Deazaguanine analog, preparation thereof and use thereof |
US7098334B2 (en) | 2002-03-25 | 2006-08-29 | Industrial Research Limited | 4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases |
EP1539783B1 (en) | 2002-08-21 | 2011-04-13 | Albert Einstein College Of Medicine Of Yeshiva University | Inhibitors of nucleoside phosphorylases and nucleosidases |
NZ523970A (en) * | 2003-02-04 | 2005-02-25 | Ind Res Ltd | Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases |
NZ533360A (en) * | 2004-06-04 | 2007-02-23 | Ind Res Ltd | Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
US20090012104A1 (en) | 2004-07-27 | 2009-01-08 | Babu Yarlagadda S | Inhibitors of 5'-Methylthioadenosine Phosphorylase and 5'-Methylthioadenosine/S-Adenosylhomocysteine Nucleosidase |
NZ540160A (en) * | 2005-05-20 | 2008-03-28 | Einstein Coll Med | Inhibitors of nucleoside phosphorylases |
EP1924684A4 (en) | 2005-07-27 | 2009-02-11 | Einstein Coll Med | STRUCTURE OF TRANSITION STATUS OF 5'-METHYLTHIOADENOSINE / S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASES |
NZ544187A (en) * | 2005-12-15 | 2008-07-31 | Ind Res Ltd | Deazapurine analogs of 1'-aza-l-nucleosides |
WO2007097647A1 (en) | 2006-02-24 | 2007-08-30 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of treating cancer |
AU2007218334A1 (en) | 2006-02-24 | 2007-08-30 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of treating diseases using inhibitors of nucleoside phosphorylases and nucleosidases |
EP2395005A1 (en) | 2006-09-07 | 2011-12-14 | Industrial Research Limited | Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
AU2007293773B2 (en) * | 2006-09-07 | 2013-01-31 | Albert Einstein College Of Medicine, Inc. | Acyclic amine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase |
CA2663562A1 (en) * | 2006-09-26 | 2008-04-03 | Vern L. Schramm | Transition state structure of human 5'-methylthioadenosine phosphorylase |
US8283345B2 (en) * | 2006-12-22 | 2012-10-09 | Industrial Research Limited | Azetidine analogues of nucleosidase and phosphorylase inhibitors |
WO2009082247A1 (en) | 2007-12-21 | 2009-07-02 | Industrial Research Limited | Process for preparing immucillins having a methylene link |
EP2348854A4 (en) | 2008-09-22 | 2012-03-14 | Einstein Coll Med | METHOD AND COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS BY INHIBITING THE "QUORUM SENSING |
WO2011008110A1 (en) | 2009-07-17 | 2011-01-20 | Albert Einstein College Of Yeshiva University | 3-hydroxypyrrolidine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase |
-
2003
- 2003-08-21 EP EP03792904A patent/EP1539783B1/en not_active Expired - Lifetime
- 2003-08-21 WO PCT/NZ2003/000186 patent/WO2004018496A1/en active Application Filing
- 2003-08-21 KR KR1020057002959A patent/KR101081226B1/ko active IP Right Grant
- 2003-08-21 AT AT03792904T patent/ATE505474T1/de active
- 2003-08-21 US US10/524,995 patent/US7553839B2/en not_active Expired - Lifetime
- 2003-08-21 SI SI200332011T patent/SI1539783T1/sl unknown
- 2003-08-21 CN CNB038243547A patent/CN100379750C/zh not_active Expired - Lifetime
- 2003-08-21 BR BRPI0313664A patent/BRPI0313664B8/pt active IP Right Grant
- 2003-08-21 RU RU2005107714/04A patent/RU2330042C2/ru active
- 2003-08-21 ES ES03792904T patent/ES2363766T3/es not_active Expired - Lifetime
- 2003-08-21 CA CA2496698A patent/CA2496698C/en not_active Expired - Lifetime
- 2003-08-21 JP JP2004530687A patent/JP4682314B2/ja not_active Expired - Lifetime
- 2003-08-21 PT PT03792904T patent/PT1539783E/pt unknown
- 2003-08-21 DE DE60336734T patent/DE60336734D1/de not_active Expired - Lifetime
- 2003-08-21 DK DK03792904.9T patent/DK1539783T3/da active
- 2003-08-21 AU AU2003258911A patent/AU2003258911B2/en not_active Expired
-
2006
- 2006-05-02 HK HK06105174A patent/HK1085219A1/xx not_active IP Right Cessation
-
2009
- 2009-06-03 US US12/455,537 patent/US8173662B2/en not_active Expired - Lifetime
-
2011
- 2011-07-12 CY CY20111100673T patent/CY1111700T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ATE505474T1 (de) | 2011-04-15 |
KR101081226B1 (ko) | 2011-11-07 |
US20060160765A1 (en) | 2006-07-20 |
CN1692120A (zh) | 2005-11-02 |
CN100379750C (zh) | 2008-04-09 |
BRPI0313664B1 (pt) | 2021-03-23 |
US20090239885A1 (en) | 2009-09-24 |
US7553839B2 (en) | 2009-06-30 |
JP4682314B2 (ja) | 2011-05-11 |
RU2005107714A (ru) | 2006-01-20 |
BRPI0313664B8 (pt) | 2021-05-25 |
EP1539783B1 (en) | 2011-04-13 |
CA2496698A1 (en) | 2004-03-04 |
RU2330042C2 (ru) | 2008-07-27 |
EP1539783A4 (en) | 2010-05-19 |
CA2496698C (en) | 2012-01-24 |
AU2003258911A1 (en) | 2004-03-11 |
KR20050093756A (ko) | 2005-09-23 |
CY1111700T1 (el) | 2015-10-07 |
ES2363766T3 (es) | 2011-08-16 |
DE60336734D1 (de) | 2011-05-26 |
BR0313664A (pt) | 2005-07-12 |
PT1539783E (pt) | 2011-06-01 |
SI1539783T1 (sl) | 2011-08-31 |
EP1539783A1 (en) | 2005-06-15 |
JP2006501239A (ja) | 2006-01-12 |
HK1085219A1 (en) | 2006-08-18 |
AU2003258911B2 (en) | 2009-11-19 |
WO2004018496A1 (en) | 2004-03-04 |
US8173662B2 (en) | 2012-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1539783T3 (da) | Inhibitorer af nucleosidphosphorylaser og nucleosidaser | |
DK1881984T3 (da) | Inhibitorer af nukleosidphosphorylaser og nukleosidaser | |
DK2057165T3 (da) | Acryliske amininhibotorer af nukleosidphosphorylaser og hydrolaser | |
CY1108146T1 (el) | ΑΝΑΣΤΟΛΕΙΣ ΤΗΣ β-ΑΜΙΝΟ-ΕΤΕΡΟΚΥΚΛΙΚΗΣ-ΔΙΠΕΠΤΙΔΥΛΙΚΗΣ ΠΕΠΤΙΔΑΣΗΣ ΓΙΑ ΤΗΝ ΑΓΩΓΗ Ή ΠΡΟΛΗΨΗ ΤΟΥ ΔΙΑΒΗΤΗ | |
CY1117217T1 (el) | Συνθεση και αντι-ιικη δραστηριοτητα των υποκατεστημενων παραγωγων αζαϊνδολοοξοοξικης πιπεραζινης | |
HRP20050417B1 (hr) | Antiviralni derivati nukleozida | |
CY1110784T1 (el) | Ιατρικη χρηση της τετρα-υδροτριαζολο[4,3-α]πυραζινης | |
MEP36208A (en) | Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers | |
CY1106933T1 (el) | Ενωσεις πυριμιδινης | |
NO20035524D0 (no) | 4'-substituerte nukleosider | |
TR200102020T2 (tr) | Raf kinaz inhibitörleri olarak w-karboksiaril sübstitüe edilmiş difenil üreler. | |
TR200103576T2 (tr) | Üre ikameli/katkılı imidazokinolinler. | |
CY1106476T1 (el) | Υποκατεστημενες διυδροκιναζολινες με αντι-ιικες ιδιοτητες | |
MY132106A (en) | New pyridazin-3(2h)-one derivatives | |
MXPA05012606A (es) | Fosforamidatos de nucleosidos como agentes anticancerigenos. | |
CY1105390T1 (el) | Θepαπευτικη αγωγη της πνευμονικης υπερτασης | |
UA85559C2 (en) | Aminobenzophenone compounds | |
DK1727817T3 (da) | Azabicyclooctan-3-onderivativer og anvendelse heraf | |
HRP20050184B1 (hr) | Uporaba alkilfosfoholina u kombinaciji s protutumorskim lijekovima | |
NO20053903L (no) | Nukleotidlipidesterderivater. | |
SE0102716D0 (sv) | Novel compounds | |
BRPI0415355A (pt) | triarilimidazóis | |
DE602004007284D1 (de) | Pyrimidine als inhibitoren von phosphoinositid-3-kinasen (pi3k) | |
TR200103398T2 (tr) | íkameli fenilsikloheksankarboksamitler ve bunlarìn adenozin alìnìmìnìn inhibitrleri olarak kullanìmì | |
RU2003119415A (ru) | Фосфорамидаты нуклеозидных аналогов-ингибиторы репродукции вируса иммунодефицита человека |